Medulloblastoma with extensive nodularity (SHH medulloblastoma)
 
More details
Hide details
 
Submission date: 2017-06-09
 
 
Acceptance date: 2017-07-08
 
 
Publication date: 2018-03-06
 
 
Pol J Pathol 2017;68(4):364-366
 
KEYWORDS
TOPICS
ABSTRACT
Medulloblastoma is the most common CNS embryonal tumor and the most common malignant tumor of childhood. Its overall incidence is 1.8 cases per 1 million people, with a childhood incidence of 6 cases per 1 million. 77 percent of patients are less than 19 years old. Medulloblastoma occurs in the 4th ventricle and usually presents with symptoms of increased intracranial pressure (headaches, nausea, vomiting) and signs of obstructive hydrocephalus. Medulloblastoma is both histologically and genetically defined with prognosis that depends on classification.
REFERENCES (5)
1.
Ellison DW, Eberhart CG, Pietsch T, Pfister S. Medulloblastoma. In: WHO Classification of Tumours of the Central Nervous System. IARC. Lyon 2016; 184-200.
 
2.
Giangaspero F, Eberhart CG, Haapasalo H, et al. Medulloblastoma. In: WHO Classification of Tumours of the Central Nervous System. IARC. Lyon 2007; 132-140.
 
3.
Taylor MD, Northcott PA, Korshunov A, et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathologica. 2012; 123: 465-472.
 
4.
Tabori U, Baskin B, Shago M, et al. Universal poor survival in children with medulloblastoma harboring somatic TP53 mutations. J Clin Oncol 2010; 28: 1345-1350.
 
5.
Ellison DW, Dalton J, Kocak M, et al. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathological 2011; 121: 381-396.
 
eISSN:2084-9869
ISSN:1233-9687
Journals System - logo
Scroll to top